Chemical Development

NUVISAN has over 40 years of experience providing clinical trial supplies services, offering a comprehensive range of solutions. These solutions include regulatory consultancy, manufacturing services, packaging and labeling, randomization list creation, analytical testing, just-in-time labeling and distrib...

State-of-the-art phase I/ll unit supporting complex clinical trials First in Human ( FIH) to Proof of Concept ( PoC) Clinical pharmacology studies through all phases In-house safety lab and bioanalytical services Special patient populations (with a focus on respiratory) Data management, regulatory sup...

With more than 40 years' experience as a Clinical Trial Supplies service provider, NUVISAN offers the full range of services in the area of clinical drug supply including: Regulatory consultancy, CMC support Non-sterile manufacturing services, including matching placebos Packaging and labelling services...

Based on an analytical continuum our testing experts provide solutions all along the value chain from early discovery to clinical trials including method development, validation, quality control, stability studies of the main physicochemical and microbiological testing for innovative and generic products.

Nuvisan experts ensure smooth clinical drug supply from phase I–IV. From supporting first-in-human to global clinical trials, we are prepared to help meet your specific challenges.

Chemical process development includes several stages: from labscale process evaluation through safety and scalability analysis, process optimisation, purification development and solid-state analyses. Our scientific team has extensive knowledge in the development of chemical processes, with a strong focus on process mass intensity (PMI), solid-phase characterisation and impurity profiling.

For over 40 years, our CRO has worked closely with pharmaceutical and biotechnology clients to support customised clinical solutions. Our experts provide solutions that meet international standards and deliver relevant strategic insights.